The 'ideal' management of retinopathy of prematurity

Eye

Volumn 19, Issue 10, 2005, Pages 1044-1049

  Quinn, G E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blindness; Premature infants; Retinopathy of prematurity

Indexed keywords

OXYGEN;

ARTICLE; BLINDNESS; CLINICAL TRIAL; CRYOTHERAPY; DEMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; HIGH RISK POPULATION; HUMAN; OPHTHALMOSCOPY; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT PLANNING; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 29244447682     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701960     Document Type: Article

References (53)

1. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet 1997; 350: 12-14.
2. Gilbert CE, Canovas R, Kocksch de Canovas R, Foster A. Causes of blindness and severe visual impairment in children in Chile. Dev Med Child Neurol 1994; 36: 326-333.
3. Quinn GE. What do we do about ROP in larger birth weight babies? Editorial, Br J Ophthalmol 2002; 86: 1072-1073.
4. Trinavarat A, Atchaneeyasakul LO, Udompunturak S. Applicability of American and British criteria for screening of the retinopathy of prematurity in Thailand. Jpn J Ophthalmol 2004; 48: 50-53.
5. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948; 68: 137-180.
6. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1: 1024-1028.
7. Pierce EA, Foley ED, Smith EH. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996; 114: 1219-1228.
8. Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004; 14(Suppl. A): S140-S144.
9. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991; 98: 1628-1640.
10. Flynn JT. Retinopathy of prematurity. Pediatr Clin N Am 1987; 34: 1487-1516.
11. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia: A nursery observation. Am J Ophthalmol 1952; 35: 1248-1252.
12. Kinsey VE, Twomey JT, Hamphill FM. Retrolental fibroplasia. Co-operative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956; 56: 481-529.
13. Silverman WA. A cautionary tale about supplemental oxygen: The albatross of neonatal medicine. Pediatrics 2004; 113: 394-396.
14. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-967.
15. Chow LC, Wright KW, Sola A, And the CSMC Oxygen Administration Study Group. Can changes in clinical practise decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339-345.
16. Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL, Pulse Oximetry Saturation Trial for Prevention of Retinopathy of Prematurity Planning Study Group. Resolving our uncertainty about oxygen therapy. Pediatrics 2003; 112(6 Part 1): 415-419.
17. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KE. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998; 116: 236-237.
18. Sacks LM, Schaffer DB, Anday EK, Peckham GJ, Delivoria-Papadopoulos M. Retrolental fibroplasias and blood transfusion in very low-birth-weight infants. Pediatrics 1981; 68: 770-774.
19. Ng YK, Fielder AR, Shaw DE, Levene MI. Epidemiology of retinopathy of prematurity. Lancet 1988; ii: 1235-1238.
20. Saunders RA, Donahue ML, Christmann LM, Palkanis AV, Tung B, Hardy RJ et al, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Racial variation in retinopathy of prematurity. Arch Ophthalmol 1997; 115: 604-608.
21. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1988; 106: 471-479.
22. Committee for the Classification of Retinopathy of Prematurity. An international classification system of retinopathy of prematurity. Arch Ophthalmol 1984; 102: 1130-1134.
23. ICROP Committee. ICROP Committee for classification of late stages of ROP: An international classification of retinopathy of prematurity: II The classification of retinal detachment. Arch Ophthalmol 1987; 105: 906-912.
24. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Natural history of Retinopathy of Prematurity (ROP): The natural ocular outcome of premature birth and retinopathy: Status at one year. Arch Ophthalmol 1994; 112: 903-912.
25. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Arch Ophthalmol 1990; 108: 195-204.
26. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One year outcome - structure and function. Arch Ophthalmol 1990; 108: 1408-1416.
27. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2 year outcome - structure and function. Arch Ophthalmol 1993; 111: 339-344.
28. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 1996; 114: 417-424.
29. Cryotherapy for Retinopathy of Prematurity Co-operative Group. Multicenter Trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 2001; 119: 110-118.
30. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999; 104: 1-8.
31. Fledelius HC, Kjer B. Surveillance for retinopathy of prematurity in a Danish county. Epimioglical experience over 20 years. Acta Ophthalmol Scand 2004; 82: 38-41.
32. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2003; 121: 1684-1696.
33. Hardy RJ, Palmer EA, Dobson V, Summer GC, Phelps DL, Quinn GE, et al., for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 2003; 121: 1697-1701.
34. Schwartz SD, Harrison SA, Ferrone PJ, Trese MT. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000; 07: 25-28.
35. Yen KG, Hess D, Burke B, Johnson RA, Feuer WJ, Flynn JT. Telephotoscreening to detect retinopathy of prematurity: Preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP. J AAPOS 2002; 6: 64-70.
36. Ells AL, Holmes JM, Astle WF, Williams G, Leske DA, Fielden M et al. Telemedicine approach to screening for severe retinopathy of prematurity: A pilot study. Ophthalmology 2003; 110: 2113-2117.
37. Saunders RA, Bluestein EC, Sinatra RB, Wilson ME, O'Neill JW, Rust PF. The predictive value of posterior pole vessels in retinopathy of prematurity. J Ped Ophthalmol Strab 1995; 32: 82-85.
38. Saunders RA, Bluestein EC, Berland JE, Donahue ML, Wilson ME, Rust PF. Can non-ophthalmologists screen for retinopathy of prematurity? J Pediatr Ophthalmol Strabismus 1995; 32: 302-304.
39. Saunders RA, Donahue ML, Berland JE, Roberts EL, Von Powers B, Rust PF. Non-ophthalmologist screening for retinopathy of prematurity. Br J Ophthalmol 2000; 84: 130-134.
40. Askie L. Appropriate levels of oxygen saturation for preterm infants. Acta Paediatr Suppl 2004; 93(444): 26-28.
41. Christiansen SP, Bradford JD. Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity. Am J Ophthalmol 1995; 119: 175-180.
42. Brown GC, Tasman WS, Naidoff M, Schaffer DB, Quinn G, Bhutani VK. Systemic complications associated with retinal cryoablation for retinopathy of prematurity. Ophthalmology 1990; 97: 855-858.
43. Quinn G, Dobson V, Barr C, Davis B, Flynn J, Palmer E et al. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity (ROP). Ophthalmology 1991; 98: 5-13.
44. Quinn GE, Dobson V, Barr CC, Davis BR, Palmer EA, Robertson J. Visual acuity of eyes after vitrectomy for ROP: Follow-up at 5-1/2 years. Ophthalmology 1996; 103: 595-600.
45. Katsumi O, Mehta MC, Matsui Y, Tetsuka H, Hirose T. Development of vision in retinopathy of prematurity. Arch Ophthalmol 1991; 109: 1394-1398.
46. Capone Jr A, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity Retinal detachments. Ophthalmology 2001; 108: 2068-2070.
47. Keith CG, Kitchen WH. Ocular morbidity in infants of very low birth weight. Br J Ophthalmol 1983; 67: 302-305.
48. Holmström G, el Azazi M, Kugelberg U. Ophthalmological long term follow up of preterm infants: A population based, prospective study of the refraction and its development. Br J Ophthalmol 1998; 82: 1265-1271.
49. Quinn GE, Dobson V, Repka MX, Reynolds J, Kivlin J, Davis B et al. Development of myopia in infants with birth weights less than 1251 g. Ophthalmology 1992; 99: 329-340.
50. Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD et al. Prevalence of myopia between three months and 5-1/2 years in preterm infants with and without retinopathy of prematurity. Ophthalmology 1998; 105: 1292-1300.
51. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Does cryotherapy affect refractive error? Ophthalmology 2001; 108: 343-347.
52. Fledelius HC. Ophthalmic changes from 10 to 18 years. A longitudinal study of sequels to low birthweight II. Visual acuity. Acta Ophthalmol 1981; 59: 64-70.
53. Kaiser RS, Trese MT, Williams GA, Cox Jr MP. Adult retinopathy of prematurity: Outcomes of rhegmatogenous retinal detachments and retinal tears. Ophthalmology 2001; 108: 1647-1653.